November/December 2018

Patients with heart failure with preserved ejection fraction (HFpEF), who face a high mortality risk and do not respond to conventional therapies, are changing the way clinicians think about heart failure.

As TAVR continues to deliver success for patients and practices, questions about volume and access have emerged.

In a back-to-the-future move, a decades-old care delivery concept is gaining momentum.

It’s becoming evident that the Stark law is frustrating the move from volume to value. Experts expect changes that could allow health systems and practices to deploy better coordinated, team-based care and advanced alternative payment models.

Major cardiology associations joined forces to update the 2012 universal definition of myocardial infarction and standardize what constitutes a heart attack.

Machine learning tools will support physicians’ efforts to deliver better patient outcomes at lower costs.

Do you remember the anticipation around renal denervation? And then the ACC.14 presentation of the SYMPLICITY HTN-3 results, where the excitement about a new way to treat resistant hypertension seemed to crash?

Taking the time to build consensus and approaching the task strategically often makes the difference between success and failure. But strategy’s never a substitute for integrity.

Cardiovascular Business asked healthcare administrators for their favorite book recommendations. Here are a few of their responses.